Apolipoprotein M Attenuates Anthracycline Cardiotoxicity and Lysosomal Injury
2023 · JACC Basic to Translational Science · 33 citations
https://doi.org/10.1016/j.jacbts.2022.09.010
C
Carla Valenzuela Ripoll
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
284
Citations
6
h-index
6
i10-index
Carla Valenzuela Ripoll is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Chemotherapy-induced cardiotoxicity and mitigation & Liver Disease and Transplantation & Autophagy in Disease and Therapy. The author has an h-index of 6, co-authored 26 publications.
ORCID: 0000-0002-6177-5227Papers by this author
worksDapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients
2025 · JACC Advances · 2 citations
https://doi.org/10.1016/j.jacadv.2025.101800
Contribution of Cardiac Macrophages and Interferon Signaling to the Therapeutic Effects of Cardiac Radiation in Heart Failure
2024 · International Journal of Radiation Oncology*Biology*Physics · 1 citations
https://doi.org/10.1016/j.ijrobp.2024.07.247
Intravenous acellular human amniotic fluid prevents ischemic cardiac remodeling
2025 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-025-28735-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat